Gain of function mutations in p53
- 1 May 1993
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 4 (1) , 42-46
- https://doi.org/10.1038/ng0593-42
Abstract
We report that the expression of murine or human mutant p53 proteins in cells with no endogenous p53 proteins confers new or additional phenotypes upon these cells. Mutant p53 proteins expressed in cell lines lacking p53 resulted in either enhanced tumorigenic potential in nude mice ((10)3 cells) or enhanced plating efficiency in agar cell culture (human SAOS–2 cells). Also, mutant human p53 alleles, unlike the wild–type p53 protein, could also enhance the expression of a test gene regulated by the multi–drug resistance enhancer–promoter element. These data demonstrate a gain of function associated with p53 mutations in addition to the loss of function shown previously to be associated with mutations in this tumour suppressor gene.Keywords
This publication has 38 references indexed in Scilit:
- Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Genes & Development, 1992
- Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.Genes & Development, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.Genes & Development, 1991
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Overproduction of p53 antigen makes established cells highly tumorigenicNature, 1985